Keros Therapeutics Inc (KROS) Reports Increased R&D Spending and Net Loss in 2023

Despite Higher Losses, KROS Advances Clinical Trials and Strengthens Cash Position

Related Keywords

,Keros Therapeutics Inc ,Hansoh Shanghai Healthtech Co Ltd ,Keros Therapeutics ,Research And Development ,Tiros ,Iopharmaceutical Company ,Anufacturing Technology Transfer Agreement ,